The story of Glaxo started with Joseph Nathan, the son of a London tailor who emigrated to Australia in 1853 at the age of 17.
After a few years, he moved to New Zealand and joined his brother-in-law in a general merchandising business, becoming a partner in 1861.
In 1873, after the partnership was dissolved, Joseph Nathan and Co was established. Strong trade links with London continued and an office there was opened in 1876.
Skimmed milk by-product from the Nathan dairy business in New Zealand - already successfully shipping butter to the UK - proved a breakthrough for the family business. A specially-built factory at Bunnythorpe in New Zealand produced milk powder that was sold mainly in bulk for catering and military customers.
With the growing use of the powder as an infant food, particularly as its health features were being realised, the Nathan family changed the name of the product from Defiance Dried Milk to Glaxo brand of milk powder, a name registered in 1906.
To manage the UK promotion of the new product, Joseph Nathan brought back from New Zealand the youngest of his three sons, Alec Nathan. It was not until 1911, during a health scare involving liquid milk, that the powdered variety proved to be a safer alternative for the bottle feeding of babies.
1873 Joseph Nathan, who lad left the UK to seek new business opportunities 20 years before, established a general trading company at Wellington in New Zealand - Joseph Nathan and Co - the foundation for the Glaxo company to be formed later.
1904 The company developed a process for producing dried milk, first sold under the brand name Defiance.
1906 Glaxo is registered by Joseph Nathan and Co, as a trademark for dried milk. The Nathan directors realised that selling dried milk as an infant food called for a more appealing name than Defiance, the name used for the New Zealand product. They settled on Lacto, but this was not acceptable because similar names were already registered. By adding and changing letters, the name Glaxo evolved and was registered in October 1906.
1908 The Glaxo department of Joseph Nathan and Co opened in London and the first "baby book" was published. The "Glaxo Baby Book" was a unique publication that aimed to answer questions from mothers about infant feeding and care. The booklet, which continued until the 1970s, provided practical advice from nursing staff and reflected the advances in medical and nutritional science. "Glaxo - the Food that Builds Bonnie Babies" became a familiar slogan in Nathan's advertising efforts of the time.
1912 Joseph Nathan died and his sons took over, the company soon becoming a household name.
World War I. Increased demand for dried milk and sales were accelerated with the First World War, and concern for the quality, safety and consistency of dried milk led to technical control improvements.
1924 The vitamin D preparation Ostelin became Glaxo's first pharmaceutical product following the obtaining of rights to a process of extracting vitamin D from fish-liver oil.
1935 Glaxo Laboratories is formed and new facilities are created at Greenford, near London.
World War II. During the Second World War, Glaxo was crucially involved in the production of penicillin and by mid-1944 was responsible for 80 per cent of the UK's penicillin doses.
1947 Glaxo Laboratories Ltd became a public company and Joseph Nathan and Co ceased to exist. Glaxo Laboratories Ltd absorbed the Joseph Nathan company and became the parent company. Glaxo was listed on the London Stock Exchange.
1948 Vitamin B12 is isolated by Glaxo scientists for the treatment of pernicious anaemia. Streptomycin for TB treatment is produced by Glaxo scientists.
1952 Acquired Dextran Ltd, manufacturers of Intradex blood plasma.
1958 Acquired Allen and Hanburys, Glaxo's first major acquisition.
1962 Company reorganisation led to the formation of Glaxo Group. Glaxo Laboratories became a subsidiary, responsible for its own production and marketing in the UK.
1962 Glaxo established a factory making baby milk at a site beside a Milk Marketing Board creamery at Kendal.
1962 Acquired Edinburgh Pharmaceutical Industries
1967 Glaxo acquired Mead Johnson's shares in BDH and subsequently the remainder of the shares. The company was renamed BDH Chemicals; a new company BDH Pharmaceuticals was formed to market pharmaceutical products made by British Drug Houses and by Duncan, Flockhart and Co and Evans Medical Supplies.
1968 Acquired Farley's Infant Food Ltd
1972 Beecham Group was unsuccessful in its bid for Glaxo Group Ltd - and Glaxo was unsuccessful in its attempt to merge with UK chemists Boots - The Beecham Group made a takeover bid for Glaxo Group and, as a defence measure, Glaxo moved to increase its size and announced a proposal to merge with UK chemists Boots. The Monopolies Commission, however, ruled after five months of investigation and deliberation that neither merger should proceed. Glaxo's parent company renamed itself Glaxo Holdings.
1976 Glaxo consolidated its food businesses, including Complan and Ostermilk, as Farley Health Products
1977 Murphy was sold to Dalgety
1978 Through the acquisition of Meyer Laboratories Inc, Glaxo's business in the US was started, to become Glaxo Inc from 1980.
1978 Murphy Chemicals (East Africa) was sold to Brooke Bond Liebig, Kenya
1986 Sold Farley Health Products to Boots
Sources of Information
- The Times, 14 December 1955
- The Times, 14 January 1961
- The Times, 3 December 1971
- The Times, 11 August 1965
- The Times, 27 October 1967
- The Times 30 March 1968
- The Times, 3 July 1968
- The Times, 22 September 1973